NO954609L - Niopecotiske syrederivater som antitrombiske forbindelser - Google Patents

Niopecotiske syrederivater som antitrombiske forbindelser

Info

Publication number
NO954609L
NO954609L NO954609A NO954609A NO954609L NO 954609 L NO954609 L NO 954609L NO 954609 A NO954609 A NO 954609A NO 954609 A NO954609 A NO 954609A NO 954609 L NO954609 L NO 954609L
Authority
NO
Norway
Prior art keywords
compounds
niopecotic
antithrombic
acid derivatives
telet
Prior art date
Application number
NO954609A
Other languages
English (en)
Other versions
NO304885B1 (no
NO954609D0 (no
Inventor
Mary Pat Beavers
Patricia Andrade-Gordon
William J Hoekstra
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO954609D0 publication Critical patent/NO954609D0/no
Publication of NO954609L publication Critical patent/NO954609L/no
Publication of NO304885B1 publication Critical patent/NO304885B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO954609A 1994-03-16 1995-11-15 Nipectoin syrederivater som antitrombe forbindelser NO304885B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21377294A 1994-03-16 1994-03-16
US36489694A 1994-12-27 1994-12-27
PCT/US1995/003145 WO1995025091A2 (en) 1994-03-16 1995-03-14 Nipecotic acid derivatives as antithrombic compounds

Publications (3)

Publication Number Publication Date
NO954609D0 NO954609D0 (no) 1995-11-15
NO954609L true NO954609L (no) 1996-01-05
NO304885B1 NO304885B1 (no) 1999-03-01

Family

ID=26908383

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954609A NO304885B1 (no) 1994-03-16 1995-11-15 Nipectoin syrederivater som antitrombe forbindelser

Country Status (20)

Country Link
US (1) US5770575A (no)
EP (1) EP0746545B1 (no)
JP (1) JPH09510453A (no)
KR (1) KR100328287B1 (no)
CN (1) CN1083834C (no)
AT (1) ATE180470T1 (no)
AU (1) AU703397B2 (no)
CA (1) CA2163027A1 (no)
DE (1) DE69509875T2 (no)
DK (1) DK0746545T3 (no)
ES (1) ES2131313T3 (no)
FI (1) FI113763B (no)
GR (1) GR3030566T3 (no)
HU (1) HUT74871A (no)
MX (1) MX9504800A (no)
NO (1) NO304885B1 (no)
NZ (1) NZ283209A (no)
RU (1) RU2135470C1 (no)
TW (1) TW318179B (no)
WO (1) WO1995025091A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT669912E (pt) * 1993-09-22 2002-03-28 Fujisawa Pharmaceutical Co Derivados de n-(3-piperidinil-carbonil)-beta-alanina como antagonistas de paf
IL117495A (en) * 1995-03-17 2002-05-23 Fujisawa Pharmaceutical Co History of b-alanine, the process for their preparation and the pharmaceutical preparations containing them
JP2000506524A (ja) * 1996-03-13 2000-05-30 藤沢薬品工業株式会社 フィブリノーゲン受容体拮抗剤であるＮ―［（Ｒ）―１―｛３―（４―ピペリジル）プロピオニル｝―３―ピペリジルカルボニル］―２（Ｓ）―アセチルアミノ―β―アラニン
UA70285C2 (en) * 1996-05-01 2004-10-15 Carboxamide derivatives of piperidine, a compositicarboxamide derivatives of piperidine, a composition based thereon and a method for treatment of thron based thereon and a method for treatment of thrombotic disorders ombotic disorders
SI0923555T1 (en) * 1996-05-01 2005-10-31 Ortho-Mcneil Pharmaceutical, Inc. Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
DE19741235A1 (de) * 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US6066651A (en) * 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
WO1999025685A1 (en) * 1997-11-18 1999-05-27 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
US6020347A (en) * 1997-11-18 2000-02-01 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
CN1351600A (zh) * 1999-03-22 2002-05-29 奥索一麦克尼尔药品公司 制备[S－(R*,S*)]－β－[[[1－[1－氧代－3－(4－(哌啶基)丙基]－3－哌啶基]羰基]氨基]－3－吡啶丙酸及其衍生物的方法
AUPQ570100A0 (en) * 2000-02-17 2000-03-09 Fujisawa Pharmaceutical Co., Ltd. Beta-alanine derivatives and their use as receptor antagonists
WO2005079863A1 (ja) 2004-02-25 2005-09-01 Astellas Pharma Inc. 血栓造影剤
EP3184149A1 (en) * 2015-12-23 2017-06-28 Julius-Maximilians-Universität Würzburg Soluble glycoprotein v for treating thrombotic diseases
CN109734655B (zh) * 2019-03-11 2020-06-02 都创(上海)医药科技有限公司 一种fkbp配体的同型二聚体合成工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
TW201303B (no) * 1990-07-05 1993-03-01 Hoffmann La Roche
IE912760A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
WO1993009795A1 (en) * 1991-11-22 1993-05-27 Yeda Research And Development Co. Ltd. Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them
US5219867A (en) * 1991-12-16 1993-06-15 Research Corporation Technologies, Inc. Platelet aggregation inhibitory agents
JP3401005B2 (ja) * 1992-12-11 2003-04-28 ユニバーシティ オブ フロリダ 有害生物の防除のための材料および方法
US5559209A (en) * 1993-02-18 1996-09-24 The General Hospital Corporation Regulator regions of G proteins

Also Published As

Publication number Publication date
NZ283209A (en) 1998-04-27
NO304885B1 (no) 1999-03-01
JPH09510453A (ja) 1997-10-21
ATE180470T1 (de) 1999-06-15
DE69509875D1 (de) 1999-07-01
FI955498A (fi) 1996-01-15
RU2135470C1 (ru) 1999-08-27
EP0746545B1 (en) 1999-05-26
EP0746545A1 (en) 1996-12-11
US5770575A (en) 1998-06-23
FI955498A0 (fi) 1995-11-15
DE69509875T2 (de) 1999-12-09
GR3030566T3 (en) 1999-10-29
CA2163027A1 (en) 1995-09-21
ES2131313T3 (es) 1999-07-16
FI113763B (fi) 2004-06-15
AU703397B2 (en) 1999-03-25
CN1083834C (zh) 2002-05-01
CN1128022A (zh) 1996-07-31
MX9504800A (es) 1997-05-31
HUT74871A (en) 1997-02-28
DK0746545T3 (da) 1999-11-08
NO954609D0 (no) 1995-11-15
WO1995025091A3 (en) 1995-10-12
AU2119195A (en) 1995-10-03
WO1995025091A2 (en) 1995-09-21
HU9503270D0 (en) 1996-05-28
KR100328287B1 (ko) 2002-10-11
TW318179B (en) 1997-10-21

Similar Documents

Publication Publication Date Title
NO971538L (no) Purin- og guaninforbindelser som inhibitorer for PNP
BR9900177A (pt) Inibidores de metaloprotease.
NO943383L (no) Substituerte pipekolinsyre-derivater som HIV-proteaseinhibitorer
NO954609L (no) Niopecotiske syrederivater som antitrombiske forbindelser
DK0594702T3 (da) Substituerede indoler som midler mod AIDS
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
NO972887D0 (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
NO20022977L (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
ES2168355T3 (es) Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa.
FI960588A (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
NO995132D0 (no) Fremgangsmåte for reduksjon av fibrinogen
NO950212D0 (no) Indolinyl-N-hydroksyurinstoff- og -N-hydroksamsyrederivater som lipoksygenase-inhibitorer
GT199400074A (es) Pirroles substituidos
AR005835A1 (es) Derivados aromaticos sustituidos del acido fosfonico.
NO20012328L (no) Fluorerte 3,4-dihydrokinolinderivater anvendt som NOS- inhibitorer